Search research articles
Contact Us
Filters
Showing results (211-220 of 1,025) with videos related to
Page
of 103
Sort By:
The American Journal of Cardiology
|
July 1, 1981
Provocative testing with ergonovine to assess the efficacy of treatment with nifedipine, diltiazem and verapamil in variant angina
D D Waters, P Théroux, J Szlachcic, et al.
Basic Life Sciences
|
January 1, 1985
Special committee report, Part I: An evaluation of current testing approaches for the detection of chemically induced aneuploidy
V L Dellarco, K H Mavournin, M D Waters
IARC Scientific Publications
|
June 3, 1999
Short-term tests for defining mutagenic carcinogens
M D Waters, H F Stack, M A Jackson
Environmental Health Perspectives
|
May 1, 1996
Human exposures to mutagens--an analysis using the genetic activity profile database
R R Tice, H F Stack, M D Waters
American Heart Journal
|
January 1, 1984
Ventricular arrhythmias during ergonovine-induced episodes of variant angina
J Szlachcic, D D Waters, D Miller, et al.
Journal of the American College of Cardiology
|
March 19, 2013
Reply: To PMID 23219296
David D Waters, S Matthijs Boekholdt, Terje R Pedersen
Mutation Research
|
November 1, 1989
Strategies for the use of computational SAR methods in assessing genotoxicity
A M Richard, J R Rabinowitz, M D Waters
Circulation
|
May 1, 1989
Exercise-induced myocardial ischemia in a cold environment. Effect of antianginal medications
M Juneau, M Johnstone, E Dempsey, et al.
In Vitro
|
November 1, 1981
Development of a toxicity test system using primary rat liver cells
J Inmon, A Stead, M D Waters, et al.
Reproduction, Fertility, and Development
|
December 3, 2025
Post-transcriptional regulatory mechanisms of dosage compensation in vertebrates
Nicholas C Lister, Kim L McIntyre, Paul D Waters
Page
of 103
Search research articles
Search
Showing results (211-220 of 1,025) with videos related to
Sort By:
Page
of 103
The American Journal of Cardiology
|
July 1, 1981
Provocative testing with ergonovine to assess the efficacy of treatment with nifedipine, diltiazem and verapamil in variant angina
D D Waters, P Théroux, J Szlachcic, et al.
Basic Life Sciences
|
January 1, 1985
Special committee report, Part I: An evaluation of current testing approaches for the detection of chemically induced aneuploidy
V L Dellarco, K H Mavournin, M D Waters
IARC Scientific Publications
|
June 3, 1999
Short-term tests for defining mutagenic carcinogens
M D Waters, H F Stack, M A Jackson
Environmental Health Perspectives
|
May 1, 1996
Human exposures to mutagens--an analysis using the genetic activity profile database
R R Tice, H F Stack, M D Waters
American Heart Journal
|
January 1, 1984
Ventricular arrhythmias during ergonovine-induced episodes of variant angina
J Szlachcic, D D Waters, D Miller, et al.
Journal of the American College of Cardiology
|
March 19, 2013
Reply: To PMID 23219296
David D Waters, S Matthijs Boekholdt, Terje R Pedersen
Mutation Research
|
November 1, 1989
Strategies for the use of computational SAR methods in assessing genotoxicity
A M Richard, J R Rabinowitz, M D Waters
Circulation
|
May 1, 1989
Exercise-induced myocardial ischemia in a cold environment. Effect of antianginal medications
M Juneau, M Johnstone, E Dempsey, et al.
In Vitro
|
November 1, 1981
Development of a toxicity test system using primary rat liver cells
J Inmon, A Stead, M D Waters, et al.
Reproduction, Fertility, and Development
|
December 3, 2025
Post-transcriptional regulatory mechanisms of dosage compensation in vertebrates
Nicholas C Lister, Kim L McIntyre, Paul D Waters
Page
of 103